Genetic, Immunological, Dietary, Gut Microbiota, and Environmental Determinants of Osteoporosis in the Course of Celiac Disease: Which Factor Plays the First Violin in This Orchestra?
-
Published:2023-12-05
Issue:2
Volume:114
Page:98-109
-
ISSN:1432-0827
-
Container-title:Calcified Tissue International
-
language:en
-
Short-container-title:Calcif Tissue Int
Author:
Skoracka KingaORCID, Hryhorowicz SzymonORCID, Tovoli FrancescoORCID, Raiteri AlbertoORCID, Rychter Anna MariaORCID, Słomski RyszardORCID, Dobrowolska AgnieszkaORCID, Granito AlessandroORCID, Krela-Kaźmierczak IwonaORCID
Abstract
AbstractCeliac disease (CD) is a chronic small intestinal immune-mediated enteropathy precipitated by exposure to dietary gluten in genetically predisposed individuals. The worldwide prevalence of CD is estimated to be 0.7–1.4% of the general population. Etiopathology of this disease is multifactorial, with genetic determinants being a major contributing player to CD susceptibility. Its manifestation embraces different organs, including the musculoskeletal apparat. Patients with CD have increased risk of bone disorders. According to data, bone disorders – osteopenia and osteoporosis – can affect up to 70% of patients with CD at diagnosis, and it decreases after the initiation of a gluten-free diet. Gluten consumption in patients with CD triggers an inflammatory reaction followed by tissue damage, and both; local and systemic inflammation can increase the risk of bone mass deterioration. Other theory assumes shortages of vitamin D and an impaired calcium absorption mechanism leading to secondary hyperparathyroidism. Taking into account the increasing prevalence of CD and osteoporosis, we broadly discuss genetic, immunological, dietary, gut microbiota, and environmental factors that could increase the risk of osteoporosis in CD. Furthermore, we discuss lifestyle and pharmacological preventing and treatment measures.
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism
Reference95 articles.
1. Ludvigsson JF, Leffler DA, Bai JC, Biagi F, Fasano A, Green PHR, Hadjivassiliou M, Kaukinen K, Kelly CP, Leonard JN, Lundin KEA, Murray JA, Sanders DS, Walker MM, Zingone F, Ciacci C (2013) The Oslo definitions for coeliac disease and related terms. Gut 62:43–52. https://doi.org/10.1136/gutjnl-2011-301346 2. Molberg O, Mcadam SN, Körner R, Quarsten H, Kristiansen C, Madsen L, Fugger L, Scott H, Norén O, Roepstorff P, Lundin KE, Sjöström H, Sollid LM (1998) Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med 4:713–717. https://doi.org/10.1038/nm0698-713 3. Makharia GK, Chauhan A, Singh P, Ahuja V (2022) Review article: epidemiology of coeliac disease. Aliment Pharmacol Ther 56:S3–S17. https://doi.org/10.1111/apt.16787 4. Roberts SE, Morrison-Rees S, Thapar N, Benninga MA, Borrelli O, Broekaert I, Dolinsek J, Martin-de-Carpi J, Mas E, Miele E, Pienar C, Ribes-Koninckx C, Thomassen RA, Thomson M, Tzivinikos C, Thorne K, John A, Williams JG (2021) Systematic review and meta-analysis: the incidence and prevalence of paediatric coeliac disease across Europe. Aliment Pharmacol Ther 54:109–128. https://doi.org/10.1111/apt.16337 5. Raiteri A, Granito A, Giamperoli A, Catenaro T, Negrini G, Tovoli F (2022) Current guidelines for the management of celiac disease: a systematic review with comparative analysis. WJG 28:154–176. https://doi.org/10.3748/wjg.v28.i1.154
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|